when was tirzepatide approved for weight loss Explained: The Future of Management Study: Tirzepatide produces greater weight

However, its efficacy may vary depending on patient compliance, exercise intensity, and duration, which poses challenges to its widespread implementation

subjective or composite endpoints

Both drugs have demonstrated benefits in reducing: Blood pressure LDL cholesterol Insulin resistance Triglycerides Given these outcomes, GLP-1 receptor agonists and dual agonists like tirzepatide are increasingly seen as metabolic multitaskers that do more than just manage weight or sugarthey protect long-term heart health and metabolic stability

Underlying insulin resistance or hormonal imbalances can limit weekly progress even with consistent semaglutide use